JP2015007144A5 - - Google Patents

Download PDF

Info

Publication number
JP2015007144A5
JP2015007144A5 JP2014212360A JP2014212360A JP2015007144A5 JP 2015007144 A5 JP2015007144 A5 JP 2015007144A5 JP 2014212360 A JP2014212360 A JP 2014212360A JP 2014212360 A JP2014212360 A JP 2014212360A JP 2015007144 A5 JP2015007144 A5 JP 2015007144A5
Authority
JP
Japan
Prior art keywords
weight
osmotic
permeable membrane
core
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014212360A
Other languages
English (en)
Japanese (ja)
Other versions
JP5941117B2 (ja
JP2015007144A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014212360A priority Critical patent/JP5941117B2/ja
Priority claimed from JP2014212360A external-priority patent/JP5941117B2/ja
Publication of JP2015007144A publication Critical patent/JP2015007144A/ja
Publication of JP2015007144A5 publication Critical patent/JP2015007144A5/ja
Application granted granted Critical
Publication of JP5941117B2 publication Critical patent/JP5941117B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014212360A 2014-10-17 2014-10-17 徐放製剤 Expired - Fee Related JP5941117B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014212360A JP5941117B2 (ja) 2014-10-17 2014-10-17 徐放製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014212360A JP5941117B2 (ja) 2014-10-17 2014-10-17 徐放製剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012513438A Division JP2012528799A (ja) 2009-06-02 2009-06-02 徐放製剤

Publications (3)

Publication Number Publication Date
JP2015007144A JP2015007144A (ja) 2015-01-15
JP2015007144A5 true JP2015007144A5 (enExample) 2015-07-02
JP5941117B2 JP5941117B2 (ja) 2016-06-29

Family

ID=52337645

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014212360A Expired - Fee Related JP5941117B2 (ja) 2014-10-17 2014-10-17 徐放製剤

Country Status (1)

Country Link
JP (1) JP5941117B2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108836948B (zh) * 2018-06-11 2024-04-12 宁波西敦医药包衣科技有限公司 一种利用包衣技术实现营养素可控制释放的产品
KR102378590B1 (ko) * 2020-09-28 2022-03-24 (주)위바이오트리 난용성 약물을 포함하는 금속 (수)산화물 복합체, 이의 제조 방법 및 이를 포함하는 약학적 조성물
CN115777937B (zh) * 2023-01-30 2023-05-16 山东瑞安泰医疗技术有限公司 一种内嵌多元营养微球的减节食胶囊及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
AP2006003602A0 (en) * 2003-09-19 2006-04-30 Sun Pharmaceutical Ind Ltd Oral drug delivery system
CN101146521A (zh) * 2005-03-14 2008-03-19 太阳医药高级研究有限公司 提供包含纤维素和甲基丙烯酸衍生物包衣的口服药物输送系统
WO2006113568A2 (en) * 2005-04-19 2006-10-26 Alza Corporation Controlled delivery dosage form of tramadol and gabapentin
EP1896002A4 (en) * 2005-06-27 2009-11-25 Biovail Lab Int Srl BUPROPIONAL SALT FORMULATIONS WITH MODIFIED RELEASE
CA2715584A1 (en) * 2008-02-15 2009-10-08 Sun Pharma Advanced Research Company Ltd. Oral controlled release tablet

Similar Documents

Publication Publication Date Title
EA201892836A1 (ru) Составы 2-[3-[4-амино-3-(2-фтор-4-феноксифенил)пиразол[3,4-d]пиримидин-1-ил]пиперидин-1-карбонил]-4-метил-4-[4-(оксетан-3-ил)пиперазин-1-ил]пент-2-еннитрила с модифицированным высвобождением
AU609916B2 (en) Sustained release pharmaceutical composition
JP2019147832A5 (enExample)
JP2014208655A5 (enExample)
HRP20230305T1 (hr) Pripravci za ileo-jejunalnu dostavu lijeka
RU2014101227A (ru) Композиция покрытия, подходящая для фармацевтических или нутрицевтических лекарственных форм
JP2014528431A5 (enExample)
HRP20180965T1 (hr) Formulacija lijeka s produženim otpuštanjem
RU2010141726A (ru) Системы доставки лекарственных веществ, включающие в себя слабоосновные лекарственные вещества и органические кислоты
JP2018500353A5 (enExample)
RU2011101918A (ru) Получение лекарственных форм миорелаксантов скелетных мышц с контролируемым высвобождением
RU2004121786A (ru) Лекарственные составы длительного высвобождения, содержащие в качестве активного соединения венлафаксина гидрохлорид
JP2006505542A5 (enExample)
JP7162014B2 (ja) 電界紡糸繊維に基づく2層生成物の製作方法
PE20091620A1 (es) Preparacion solida de desintegracion oral
JP2010518002A5 (enExample)
JP2016500088A5 (enExample)
JP2015007144A5 (enExample)
JP2012082195A5 (enExample)
HRP20211269T1 (hr) Kompozicije prolijeka na bazi monometil fumarata
ES2914378T3 (es) Capas adhesivas de polímeros solubles en agua
RU2015138784A (ru) Фармацевтическая композиция в виде мультичастиц, содержащая множество гранул двух видов
RU2013150254A (ru) Пероральный твердый препарат комбинированного противотуберкулезного лекарственного средства и способ его получения
RU2015140119A (ru) Таблетка, покрытая кишечнорастворимым покрытием
AR071970A1 (es) Composicion de liberacion pulsatil de sildenafil y proceso para prepararla